Texas Permanent School Fund Raises Stock Holdings in NextGen Healthcare, Inc. (NASDAQ:NXGN)

Texas Permanent School Fund grew its stake in NextGen Healthcare, Inc. (NASDAQ:NXGNGet Rating) by 1.9% during the 2nd quarter, Holdings Channel reports. The fund owned 40,596 shares of the company’s stock after acquiring an additional 776 shares during the period. Texas Permanent School Fund’s holdings in NextGen Healthcare were worth $708,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Nisa Investment Advisors LLC purchased a new stake in shares of NextGen Healthcare in the first quarter valued at $63,000. First Horizon Advisors Inc. lifted its position in NextGen Healthcare by 33.0% during the second quarter. First Horizon Advisors Inc. now owns 3,784 shares of the company’s stock worth $66,000 after buying an additional 939 shares during the period. Captrust Financial Advisors lifted its position in NextGen Healthcare by 61.5% during the first quarter. Captrust Financial Advisors now owns 4,255 shares of the company’s stock worth $89,000 after buying an additional 1,620 shares during the period. KBC Group NV purchased a new position in NextGen Healthcare during the second quarter worth about $82,000. Finally, GSA Capital Partners LLP purchased a new position in NextGen Healthcare during the first quarter worth about $208,000. 73.80% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Mitchell Waters sold 9,783 shares of the stock in a transaction dated Tuesday, November 8th. The stock was sold at an average price of $20.50, for a total value of $200,551.50. Following the completion of the sale, the executive vice president now owns 70,469 shares in the company, valued at $1,444,614.50. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other news, CTO David A. Metcalfe sold 32,372 shares of the stock in a transaction dated Tuesday, November 1st. The stock was sold at an average price of $20.00, for a total value of $647,440.00. Following the completion of the sale, the chief technology officer now owns 178,984 shares in the company, valued at $3,579,680. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Mitchell Waters sold 9,783 shares of the stock in a transaction dated Tuesday, November 8th. The shares were sold at an average price of $20.50, for a total value of $200,551.50. Following the completion of the sale, the executive vice president now owns 70,469 shares of the company’s stock, valued at approximately $1,444,614.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 78,416 shares of company stock worth $1,580,010. 4.50% of the stock is currently owned by corporate insiders.

NextGen Healthcare Price Performance

Shares of NASDAQ:NXGN opened at $20.17 on Monday. The firm has a market capitalization of $1.36 billion, a PE ratio of 65.06 and a beta of 1.00. The business has a 50-day moving average of $18.53 and a two-hundred day moving average of $18.01. NextGen Healthcare, Inc. has a 12 month low of $15.32 and a 12 month high of $21.99.

Analyst Ratings Changes

Several research firms recently weighed in on NXGN. Truist Financial began coverage on NextGen Healthcare in a research report on Wednesday, September 7th. They set a “hold” rating and a $20.00 target price on the stock. TheStreet upgraded NextGen Healthcare from a “c” rating to a “b-” rating in a research report on Wednesday, October 26th. Piper Sandler reiterated a “neutral” rating and set a $20.00 target price on shares of NextGen Healthcare in a research report on Friday, October 21st. StockNews.com upgraded NextGen Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Thursday, October 27th. Finally, SVB Leerink upped their price target on NextGen Healthcare from $24.00 to $25.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 26th. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $22.75.

NextGen Healthcare Company Profile

(Get Rating)

NextGen Healthcare, Inc provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions.

Featured Stories

Want to see what other hedge funds are holding NXGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NextGen Healthcare, Inc. (NASDAQ:NXGNGet Rating).

Institutional Ownership by Quarter for NextGen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.